Mutant EGFR inhibitor structure
|
Common Name | Mutant EGFR inhibitor | ||
---|---|---|---|---|
CAS Number | 1421373-62-7 | Molecular Weight | 520.02600 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C27H30ClN7O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Mutant EGFR inhibitorMutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. |
Name | N-(5-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide |
---|---|
Synonym | More Synonyms |
Description | Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. |
---|---|
Related Catalog | |
Target |
EGFRL858R EGFRExon 19 deletion EGFRT790M |
References |
[1]. WO 2013014448 A1 |
Molecular Formula | C27H30ClN7O2 |
---|---|
Molecular Weight | 520.02600 |
Exact Mass | 519.21500 |
PSA | 98.41000 |
LogP | 5.29880 |
Storage condition | 2-8℃ |
N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-(2-dimethylaminoethylmethylamino)-4-methoxyphenyl]prop-2-enamide |
Mutant EGFR inhibitor |